Form 4 for CABA Cabaletta Bio, Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-21 · accession 0001193125-26-018318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-21 | CABA | Nichtberger Steven | Pres, CEO, Dir | P - Purchase | $2.24 | +45.0K | 1.03M | +5% | +$100.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | P | A | 45,000 | $2.24 | 1,031,483 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $2.1985 to $2.26, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |